Review
Version 1
Preserved in Portico This version is not peer-reviewed
How Can Artificial Intelligent Be Implemented Effectively in Diabetic Retinopathy Screening in Japan?
Version 1
: Received: 9 January 2024 / Approved: 10 January 2024 / Online: 10 January 2024 (13:10:15 CET)
A peer-reviewed article of this Preprint also exists.
Kawasaki, R. How Can Artificial Intelligence Be Implemented Effectively in Diabetic Retinopathy Screening in Japan? Medicina 2024, 60, 243. Kawasaki, R. How Can Artificial Intelligence Be Implemented Effectively in Diabetic Retinopathy Screening in Japan? Medicina 2024, 60, 243.
Abstract
In conclusion, this review highlights the challenges in the current screening pathway and the potential for AI, particularly LLM, to revolutionize DR screening in Japan. The future direction will depend on leadership from ophthalmologists and stakeholders to address long-standing challenges in DR screening so that all people have access to accessible and effective screening.
Keywords
diabetic retinopathy; artificial intelligence; systematic screening
Subject
Public Health and Healthcare, Public Health and Health Services
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment